Salveen Richter
Stock Analyst at Goldman Sachs
(4.37)
# 1,139
Out of 4,362 analysts
491
Total ratings
45.4%
Success rate
9.7%
Average return
Main Sectors:
Stocks Rated by Salveen Richter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RLAY Relay Therapeutics | Maintained: Buy | $22 | $15.30 | +43.79% | 11 | Jun 2, 2026 | |
| PFS Provident Financial Services | Maintained: Buy | $41 | $21.54 | +90.34% | 1 | Jun 1, 2026 | |
| AGIO Agios Pharmaceuticals | Maintained: Hold | $32 | $27.68 | +15.61% | 15 | Jun 1, 2026 | |
| APGE Apogee Therapeutics | Initiated Coverage: Hold | $89 | $84.19 | +5.71% | 1 | May 28, 2026 | |
| REGN Regeneron Pharmaceuticals | Maintained: Buy | $968 | $618.95 | +56.39% | 23 | May 18, 2026 | |
| BIIB Biogen | Maintained: Buy | $238 → $250 | $195.96 | +27.58% | 30 | May 15, 2026 | |
| IMNM Immunome | Maintained: Buy | $35 | $19.81 | +76.68% | 3 | May 13, 2026 | |
| ANNX Annexon | Initiated Coverage: Hold | $7 | $5.39 | +29.87% | 1 | May 12, 2026 | |
| BMRN BioMarin Pharmaceutical | Initiated Coverage: Hold | $127 → $69 | $54.66 | +26.23% | 17 | May 11, 2026 | |
| NTLA Intellia Therapeutics | Maintained: Sell | $9 | $13.02 | -30.88% | 16 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $130 | $128.99 | +0.78% | 14 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $39 → $59 | $36.03 | +63.75% | 4 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $38 → $33 | $9.53 | +246.27% | 12 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $10 → $14 | $29.88 | -53.15% | 20 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $14 → $16 | $15.56 | +2.83% | 2 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $625 → $641 | $428.34 | +49.65% | 25 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $415 → $425 | $338.22 | +25.66% | 19 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $41 | $15.07 | +172.06% | 3 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $43 → $49 | $49.06 | -0.12% | 44 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $549 → $550 | $292.58 | +87.98% | 21 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $50 | $32.83 | +52.30% | 1 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $51 | $37.00 | +37.84% | 2 | Apr 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 → $26 | $12.91 | +101.39% | 2 | Apr 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $61 → $25 | $22.41 | +11.56% | 12 | Mar 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $11 | $5.55 | +98.20% | 5 | Mar 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $65 → $72 | $73.82 | -2.47% | 13 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $19 → $17 | $16.24 | +4.68% | 23 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $90 → $98 | $97.98 | +0.02% | 23 | Feb 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $16 | $23.86 | -32.94% | 6 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $15 → $17 | $21.43 | -20.67% | 11 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $19 | $10.87 | +74.79% | 1 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $47 → $48 | $52.08 | -7.83% | 15 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $46 → $40 | $19.66 | n/a | 13 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $9.63 | n/a | 9 | Dec 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $39 | $2.92 | n/a | 1 | Apr 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $37 → $30 | $18.34 | n/a | 3 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $48 → $5 | $15.99 | n/a | 8 | Feb 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $65.48 | n/a | 1 | Jan 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $54.72 | n/a | 1 | Jan 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $53 | $54.97 | n/a | 1 | Jul 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $7 | $2.78 | n/a | 2 | Jun 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $42 → $4.25 | $39.85 | n/a | 2 | May 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $32 → $31 | $2.00 | n/a | 10 | Mar 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $225 | $229.60 | n/a | 2 | Feb 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $22 | $3.14 | n/a | 1 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $30 → $7 | $12.57 | n/a | 2 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $2 → $1 | $6.04 | n/a | 4 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $8 → $9 | $3.47 | n/a | 4 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $34 → $6 | $3.12 | n/a | 4 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $28 → $30 | $5.97 | n/a | 3 | Mar 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $126 → $131 | $488.15 | n/a | 7 | Mar 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $11 | $3.09 | n/a | 5 | Nov 9, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $40 | $6.33 | n/a | 1 | Oct 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $45 → $47 | $72.55 | n/a | 2 | May 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $4 → $2 | $6.85 | n/a | 3 | Nov 13, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $44 → $76 | $549.47 | n/a | 3 | Oct 29, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $18 → $2 | $2.61 | n/a | 2 | Oct 15, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $13 | $0.001 | n/a | 1 | Dec 2, 2011 |
Relay Therapeutics
Jun 2, 2026
Maintained: Buy
Price Target: $22
Current: $15.30
Upside: +43.79%
Provident Financial Services
Jun 1, 2026
Maintained: Buy
Price Target: $41
Current: $21.54
Upside: +90.34%
Agios Pharmaceuticals
Jun 1, 2026
Maintained: Hold
Price Target: $32
Current: $27.68
Upside: +15.61%
Apogee Therapeutics
May 28, 2026
Initiated Coverage: Hold
Price Target: $89
Current: $84.19
Upside: +5.71%
Regeneron Pharmaceuticals
May 18, 2026
Maintained: Buy
Price Target: $968
Current: $618.95
Upside: +56.39%
Biogen
May 15, 2026
Maintained: Buy
Price Target: $238 → $250
Current: $195.96
Upside: +27.58%
Immunome
May 13, 2026
Maintained: Buy
Price Target: $35
Current: $19.81
Upside: +76.68%
Annexon
May 12, 2026
Initiated Coverage: Hold
Price Target: $7
Current: $5.39
Upside: +29.87%
BioMarin Pharmaceutical
May 11, 2026
Initiated Coverage: Hold
Price Target: $127 → $69
Current: $54.66
Upside: +26.23%
Intellia Therapeutics
May 11, 2026
Maintained: Sell
Price Target: $9
Current: $13.02
Upside: -30.88%
May 8, 2026
Maintained: Hold
Price Target: $130
Current: $128.99
Upside: +0.78%
May 8, 2026
Maintained: Buy
Price Target: $39 → $59
Current: $36.03
Upside: +63.75%
May 8, 2026
Maintained: Buy
Price Target: $38 → $33
Current: $9.53
Upside: +246.27%
May 6, 2026
Maintained: Hold
Price Target: $10 → $14
Current: $29.88
Upside: -53.15%
May 4, 2026
Maintained: Hold
Price Target: $14 → $16
Current: $15.56
Upside: +2.83%
May 4, 2026
Maintained: Buy
Price Target: $625 → $641
Current: $428.34
Upside: +49.65%
May 1, 2026
Rated: Buy
Price Target: $415 → $425
Current: $338.22
Upside: +25.66%
May 1, 2026
Maintained: Buy
Price Target: $41
Current: $15.07
Upside: +172.06%
May 1, 2026
Maintained: Hold
Price Target: $43 → $49
Current: $49.06
Upside: -0.12%
Apr 30, 2026
Maintained: Buy
Price Target: $549 → $550
Current: $292.58
Upside: +87.98%
Apr 30, 2026
Maintained: Buy
Price Target: $50
Current: $32.83
Upside: +52.30%
Apr 21, 2026
Maintained: Buy
Price Target: $51
Current: $37.00
Upside: +37.84%
Apr 9, 2026
Maintained: Buy
Price Target: $14 → $26
Current: $12.91
Upside: +101.39%
Mar 24, 2026
Downgraded: Hold
Price Target: $61 → $25
Current: $22.41
Upside: +11.56%
Mar 19, 2026
Maintained: Buy
Price Target: $11
Current: $5.55
Upside: +98.20%
Feb 25, 2026
Maintained: Hold
Price Target: $65 → $72
Current: $73.82
Upside: -2.47%
Feb 25, 2026
Maintained: Hold
Price Target: $19 → $17
Current: $16.24
Upside: +4.68%
Feb 11, 2026
Maintained: Hold
Price Target: $90 → $98
Current: $97.98
Upside: +0.02%
Oct 30, 2025
Maintained: Hold
Price Target: $16
Current: $23.86
Upside: -32.94%
Aug 7, 2025
Maintained: Sell
Price Target: $15 → $17
Current: $21.43
Upside: -20.67%
Aug 7, 2025
Maintained: Hold
Price Target: $19
Current: $10.87
Upside: +74.79%
Aug 5, 2025
Maintained: Hold
Price Target: $47 → $48
Current: $52.08
Upside: -7.83%
Jan 28, 2025
Maintained: Buy
Price Target: $46 → $40
Current: $19.66
Upside: n/a
Dec 19, 2024
Rated: Hold
Price Target: n/a
Current: $9.63
Upside: n/a
Apr 2, 2024
Initiated Coverage: Hold
Price Target: $39
Current: $2.92
Upside: n/a
Mar 5, 2024
Maintained: Buy
Price Target: $37 → $30
Current: $18.34
Upside: n/a
Feb 16, 2024
Maintained: Hold
Price Target: $48 → $5
Current: $15.99
Upside: n/a
Jan 8, 2024
Maintained: Buy
Price Target: n/a
Current: $65.48
Upside: n/a
Jan 5, 2024
Maintained: Buy
Price Target: n/a
Current: $54.72
Upside: n/a
Jul 31, 2023
Maintained: Buy
Price Target: $53
Current: $54.97
Upside: n/a
Jun 12, 2023
Maintained: Sell
Price Target: $7
Current: $2.78
Upside: n/a
May 15, 2023
Maintained: Hold
Price Target: $42 → $4.25
Current: $39.85
Upside: n/a
Mar 1, 2023
Maintained: Buy
Price Target: $32 → $31
Current: $2.00
Upside: n/a
Feb 24, 2023
Maintained: Buy
Price Target: $225
Current: $229.60
Upside: n/a
Nov 14, 2022
Initiated Coverage: Hold
Price Target: $22
Current: $3.14
Upside: n/a
Nov 11, 2022
Downgraded: Hold
Price Target: $30 → $7
Current: $12.57
Upside: n/a
Nov 10, 2022
Maintained: Hold
Price Target: $2 → $1
Current: $6.04
Upside: n/a
Nov 9, 2022
Maintained: Hold
Price Target: $8 → $9
Current: $3.47
Upside: n/a
Nov 3, 2022
Maintained: Hold
Price Target: $34 → $6
Current: $3.12
Upside: n/a
Mar 4, 2021
Upgraded: Buy
Price Target: $28 → $30
Current: $5.97
Upside: n/a
Mar 1, 2021
Maintained: Hold
Price Target: $126 → $131
Current: $488.15
Upside: n/a
Nov 9, 2020
Maintained: Sell
Price Target: $11
Current: $3.09
Upside: n/a
Oct 28, 2020
Downgraded: Hold
Price Target: $40
Current: $6.33
Upside: n/a
May 8, 2020
Maintained: Hold
Price Target: $45 → $47
Current: $72.55
Upside: n/a
Nov 13, 2019
Maintained: Sell
Price Target: $4 → $2
Current: $6.85
Upside: n/a
Oct 29, 2013
Rated: Hold
Price Target: $44 → $76
Current: $549.47
Upside: n/a
Oct 15, 2013
Downgraded: Hold
Price Target: $18 → $2
Current: $2.61
Upside: n/a
Dec 2, 2011
Initiated Coverage: Buy
Price Target: $13
Current: $0.001
Upside: n/a